Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Ovarian Neoplasms 69Fallopian Tube Neoplasms 18Endometrial Neoplasms 8Carcinoma, Ovarian Epithelial 8Breast Neoplasms 7Neoplasms 5Pancreatic Neoplasms 3Cystadenocarcinoma, Serous 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Prostatic Neoplasms 2Ovarian Diseases 2Neoplasm Metastasis 2Gonadal Disorders 2Genital Neoplasms, Female 2Genital Diseases, Female 2Endocrine System Diseases 2Endocrine Gland Neoplasms 2Carcinoma 2Adnexal Diseases 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Thrombocytopenia 1Sarcoma 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Recurrence 1Prostatic Diseases 1Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1Platinum-resistant Ovarian Cancer 1

Interventions

rucaparib 1pembrolizumab 1niraparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Male × niraparib × Gynecologic × Clear all
NCT00749502 2013-07-25

A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Tesaro, Inc.

Phase 1 Completed
113 enrolled
GenitourinaryGynecologicLymphoidOther hematologic neoplasm

Adnexal Diseases, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Diseases, Male, Genital Neoplasms, Female, Genital Neoplasms, Male, Gonadal Disorders, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡